Add Yahoo as a preferred source to see more of our stories on Google. Eli Lilly announced on "Good Morning America" Monday that its GLP-1 weight-loss drug Zepbound will now be available in a new multi ...
Credit: Lilly. The 4-dose KwikPen device supports weight reduction in patients with obesity or overweight with weight-related conditions. The device is for single-patient use only and should never be ...
The FDA has approved a new four-dose, single-patient-use KwikPen for Zepbound (tirzepatide), giving patients a full month of treatment in one device. Lilly says the new pen expands patient choice, ...
Please provide your email address to receive an email when new articles are posted on . The Zepbound KwikPen allows patients to receive four doses of the drug in a single pen device. According to Eli ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results